Literature DB >> 29793770

[The respiratory effects of smoking].

G Peiffer1, M Underner2, J Perriot3.   

Abstract

A marked increase in the morbidity and mortality of a large number of broncho-pulmonary diseases has been documented in relation to smoking. The influence of tobacco smoking on various respiratory conditions. is discussed: incidence, severity or natural history modification of some respiratory illnesses: obstructive lung diseases (COPD, asthma), lung cancer, bacterial, viral respiratory infections, with the impact of smoking on tuberculosis. Finally, the relationship of tobacco with diffuse interstitial lung disease: protective role of smoking (controversial in sarcoidosis, real in hypersensitivity pneumonitis). The benefits of smoking cessation are described.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Asthma; Asthme; BPCO; COPD; Cancer bronchique; Interstitial diseases; Lung; Lung cancer; Maladies interstitielles; Poumon; Smoking; Tabagisme

Mesh:

Year:  2018        PMID: 29793770     DOI: 10.1016/j.pneumo.2018.04.009

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  4 in total

1.  Smoking Prevalence and COVID-19 in Europe.

Authors:  Panagiotis Tsigaris; Jaime A Teixeira da Silva
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

2.  Response to the Comment on "A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19".

Authors:  Jesus González-Rubio; Carmen Navarro-López; Elena López-Najera; Ana López-Najera; Lydia Jiménez-Díaz; Juan D Navarro-López; Alberto Najera
Journal:  Int J Environ Res Public Health       Date:  2020-12-21       Impact factor: 3.390

3.  Change of Dietary and Lifestyle Habits during and after the COVID-19 Lockdown in Cyprus: An Analysis of Two Observational Studies.

Authors:  Maria Kyprianidou; Stavri Chrysostomou; Costas A Christophi; Konstantinos Giannakou
Journal:  Foods       Date:  2022-07-06

4.  Clinical relevance of miR-423-5p levels in chronic obstructive pulmonary disease patients.

Authors:  Xin Zhang; Qing Shi; Lu Xiong; Shiye Shi; Yong Li; Yanhuan Wang; Mingchuan Zhang
Journal:  Clinics (Sao Paulo)       Date:  2022-09-23       Impact factor: 2.898

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.